Skip to content
10-K

Annual Report

ImmunityBio, Inc. IBRX

0001326110-26-000030

← back to feed
Filed
Feb 23, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 1.03B sh
Shares Diluted FY 2025 · Dec 31, 2025 919.86M sh
Shares Diluted FY 2025 · Dec 31, 2024 700.44M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 508.64M sh
Capex FY 2025 · Dec 31, 2025 $3.85M
Capex FY 2025 · Dec 31, 2024 $6.89M
Capex FY 2025 · Dec 31, 2023 $30.58M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$304.94M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$391.24M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$366.76M
Short Term Debt FY 2025 · Dec 31, 2025 $1.75M
Short Term Debt FY 2025 · Dec 31, 2024 $1.25M
Cash And Equivalents FY 2025 · Dec 31, 2025 $88.33M
Cash And Equivalents FY 2025 · Dec 31, 2024 $143.43M
Cash And Equivalents FY 2025 · Dec 31, 2023 $265.45M
Stockholders Equity FY 2025 · Dec 31, 2025 −$500.47M
Stockholders Equity FY 2025 · Dec 31, 2024 −$489.1M
Current Liabilities FY 2025 · Dec 31, 2025 $61.75M
Current Liabilities FY 2025 · Dec 31, 2024 $54.94M
Total Liabilities FY 2025 · Dec 31, 2025 $1B
Total Liabilities FY 2025 · Dec 31, 2024 $871.06M
Current Assets FY 2025 · Dec 31, 2025 $314.88M
Current Assets FY 2025 · Dec 31, 2024 $184.59M
Total Assets FY 2025 · Dec 31, 2025 $501.9M
Total Assets FY 2025 · Dec 31, 2024 $382.93M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.38
Eps Diluted FY 2025 · Dec 31, 2024 −$0.62
Eps Diluted FY 2025 · Dec 31, 2023 −$1.15
Eps Basic FY 2025 · Dec 31, 2025 −$0.38
Eps Basic FY 2025 · Dec 31, 2024 −$0.59
Eps Basic FY 2025 · Dec 31, 2023 −$1.15
Net Income FY 2025 · Dec 31, 2025 −$351.4M
Net Income FY 2025 · Dec 31, 2024 −$413.56M
Net Income FY 2025 · Dec 31, 2023 −$583.2M
Operating Income FY 2025 · Dec 31, 2025 −$256.03M
Operating Income FY 2025 · Dec 31, 2024 −$344.18M
Operating Income FY 2025 · Dec 31, 2023 −$362.25M
Cost Of Revenue FY 2025 · Dec 31, 2025 $753K
Cost Of Revenue FY 2025 · Dec 31, 2024 $0
Cost Of Revenue FY 2025 · Dec 31, 2023 $0
Revenue FY 2025 · Dec 31, 2025 $113.29M
Revenue FY 2025 · Dec 31, 2024 $14.75M
Revenue FY 2025 · Dec 31, 2023 $622K